Thorax 1999;54:301-307 ( April )

Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma

Hilary F Guite, Ruth Dundas, Peter G J Burney

Department of Public Health Medicine, Bromley Health, Global House, 10 Station Approach, Hayes, Kent BR2 7EH, UK

Correspondence to: Dr H Guite.

Received 29 June 1998; Returned to authors 3 September 1998; Revised version received 23 November 1998; Accepted for publication 11 December 1998

BACKGROUNDPatients with asthma have an increased risk of death from causes other than asthma. A study was undertaken to identify whether severity of asthma, its treatment, or associated co-morbidity were associated with increased risk of death from other causes.
METHODSEighty five deaths from all causes occurring within three years of discharge from hospital in a cohort of 2242 subjects aged 16-64 years admitted for asthma were compared with a random sample of 61 controls aged <45 years and 61 aged 45 years from the same cohort.
RESULTSDeaths from asthma were associated with a history of clinically severe asthma (OR 6.29 (95% CI 1.84 to 21.52)), chest pain (OR 3.78 (95% CI 1.06 to 13.5)), biochemical or haematological abnormalities at admission (OR 4.12 (95% CI 1.36 to 12.49)), prescription of ipratropium bromide (OR 4.04 (95% CI 1.47 to 11.13)), and failure to prescribe inhaled steroids on discharge (OR 3.45 (95% CI 1.35 to 9.10)). Deaths from chronic obstructive pulmonary disease (COPD) were associated with lower peak expiratory flow rates (OR 2.56 (95% CI 1.52 to 4.35) for each 50 l/min change), a history of smoking (OR 5.03 (95% CI 1.17 to 21.58)), prescription of ipratropium bromide (OR 7.75 (95% CI 2.21 to 27.14)), and failure to prescribe inhaled steroids on discharge (OR 3.33 (95% CI 0.95 to 11.10)). Cardiovascular deaths were more common among those prescribed ipratropium bromide on discharge (OR 3.55 (95% CI 1.05 to 11.94)) and less likely in those admitted after an upper respiratory tract infection (OR 0.21 (95% CI 0.05 to 0.95)). Treatment with ipratropium bromide at discharge was associated with an increased risk of death from asthma even after adjusting for peak flow, COPD and cardiovascular co-morbidity, ever having smoked, and age at onset of asthma.
CONCLUSIONSPrescription of inhaled steroids on discharge is important even for those patients with co-existent COPD and asthma. Treatment with ipratropium at discharge is associated with increased risk of death from asthma even after adjustment for a range of markers of COPD. These results need to be tested in larger studies.

Keywords: death; asthma; chronic obstructive pulmonary disease; cardiovascular disease; risk factors

---

© 1999 by Thorax
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Enright, P. (2006). Does Screening for COPD by Primary Care Physicians Have the Potential to Cause More Harm Than Good?. Chest 129: 833-835 [Full Text]  
• Anderson, H R., Ayres, J. G, Sturdy, P. M, Bland, J M., Butland, B. K, Peckitt, C., Taylor, J. C, Victor, C. R, for the Mortality and Severe Morbidity Group of th, (2005). Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330: 117- [Abstract] [Full Text]  
• Iribarren, C., Tolstykh, I. V, Eisner, M. D (2004). Are patients with asthma at increased risk of coronary heart disease?. Int J Epidemiol 33: 743-748 [Abstract] [Full Text]  
• Raymond, L. W. (2004). Vagal Pas de Deux: Heart-Lung Interplay in Postexercise Heart Rate Recovery. Chest 125: 1186-1190 [Full Text]  
• Vandentorren, S., Baldi, I., Annesi Maesano, I., Charpin, D., Neukirch, F., Filleul, L., Cantagrel, A., Tessier, J.F. (2003). Long-term mortality among adults with or without asthma in the PAARC study. Eur Respir J 21: 462-467 [Abstract] [Full Text]  
• Sturdy, P M, Victor, C R, Anderson, H R, Bland, J M, Butland, B K, Harrison, B D W, Peckitt, C, Taylor, J C (2002). Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 57: 1034-1039 [Abstract] [Full Text]  
• Anthonisen, N. R., Connett, J. E., Enright, P. L., Manfreda, J. (2002). Hospitalizations and Mortality in the Lung Health Study. Am. J. Respir. Crit. Care Med. 166: 333-339 [Abstract] [Full Text]  
• Sin, D. D., Man, S. F. P. (2002). Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for Asthma. Arch Intern Med 162: 1591-1595 [Abstract] [Full Text]  
• Curtis, B. M., O'Keefe, J. H. Jr (2002). Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight. Mayo Clin Proc. 77: 45-54 [Abstract]  
• Kips, J C, Pauwels, R A (2001). Low dose inhaled corticosteroids and the prevention of death from asthma. Thorax 56: ii74-78 [Full Text]  
• Sin, D.D., Tu, J.V. (2001). Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J 17: 380-385 [Abstract] [Full Text]  
• Sin, D. D, Tu, J. V (2000). Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease. Thorax 55: 194-197 [Abstract] [Full Text]  
• LANES, S. F, WILSON;, J D., GUITE, H., DUNDAS, R., BURNEY, P. (2000). Nebulised taurolidine and B cepacia bronchiectasis.. Thorax 55: 91-92 [Full Text]  
• (1999). Other Articles Noted. Evid. Based Nurs. 2: 105-112 [Full Text]